Get the Stockscreener App
7.54
2.20%
-0.17
Sight Sciences Inc stock is traded at $7.54, with a volume of 9,335.
It is down -2.20% in the last 24 hours and down -6.34% over the past month.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
See More
Previous Close:
$7.71
Open:
$7.61
24h Volume:
9,335
Relative Volume:
0.04
Market Cap:
$398.65M
Revenue:
$81.06M
Net Income/Loss:
$-55.55M
P/E Ratio:
-6.614
EPS:
-1.14
Net Cash Flow:
$-47.98M
1W Performance:
-5.75%
1M Performance:
-6.34%
6M Performance:
+79.10%
1Y Performance:
+121.76%
1-Day Range:
$7.41
$7.61
1-Week Range:
$7.28
$8.45
52-Week Range:
$2.03
$9.2362
Sight Sciences Inc Stock (SGHT) Company Profile
Name
Sight Sciences Inc
Sector
Industry
Phone
(415) 889-0550
Address
4040 CAMPBELL AVE,, MENLO PARK
Compare SGHT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SGHT
Sight Sciences Inc
|
7.54 | 407.64M | 81.06M | -55.55M | -47.98M | -1.14 |
|
ABT
Abbott Laboratories
|
128.41 | 219.88B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.54 | 141.54B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
355.37 | 133.39B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.75 | 124.82B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.69 | 48.84B | 5.88B | 1.34B | 799.60M | 2.3489 |
Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-05-26 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-08-25 | Upgrade | Lake Street | Hold → Buy |
| Dec-06-24 | Initiated | UBS | Buy |
| Nov-04-24 | Downgrade | Lake Street | Buy → Hold |
| Aug-21-24 | Initiated | Lake Street | Buy |
| Sep-12-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-12-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-12-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Aug-24-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-10-23 | Downgrade | Citigroup | Buy → Neutral |
| Jan-06-23 | Upgrade | Stifel | Hold → Buy |
| Oct-04-22 | Initiated | Needham | Hold |
| Jul-26-22 | Initiated | Stifel | Hold |
| Feb-03-22 | Initiated | William Blair | Outperform |
| Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
View All
Sight Sciences Inc Stock (SGHT) Latest News
Piper Sandler upgrades Sight Sciences stock rating to Overweight By Investing.com - Investing.com Nigeria
Published on: 2026-01-06 08:42:12 - earlytimes.in
What drives Sight Sciences Inc stock priceTechnical Analysis Insights & Capital Growth Strategies - earlytimes.in
Piper Sandler upgrades Sight Sciences on strong business prospects - TradingView — Track All Markets
Sight sciences CTO David Badawi sells $15,081 in stock - MSN
The Truth About Sight Sciences Inc (SGHT): Silent Wall Street Underdog Or Total Flop? - AD HOC NEWS
Sight Sciences: Improving Medicare Coverage Drives Eye-Popping Price Surge (NASDAQ:SGHT) - Seeking Alpha
Piper Sandler upgrades Sight Sciences stock rating to Overweight - Investing.com
What analysts say about Sight Sciences Inc stockCovered Call Writing & Free Trading Signals to Sharpen Your Edge - earlytimes.in
Sight Sciences (SGHT) price target increased by 22.34% to 8.01 - MSN
Institutions profited after Sight Sciences, Inc.'s (NASDAQ:SGHT) market cap rose US$48m last week but individual investors profited the most - simplywall.st
Sight Sciences price target raised to $12 from $7 at UBS - Yahoo Finance
UBS Maintains Sight Sciences (SGHT) Buy Recommendation - Nasdaq
SGHT’s price-to-cash ratio: Is it a good investment at the moment? - uspostnews.com
What makes Sight Sciences, Inc. (SGHT) a strong momentum stock: Buy now? - MSN
Sight Sciences (SGHT) Price Target Increased by 22.34% to 8.01 - Nasdaq
Will Sight Sciences Inc. stock benefit from sector rotationTrade Volume Summary & Low Drawdown Momentum Trade Ideas - Улправда
How resilient is Sight Sciences Inc. stock in market downturnsPortfolio Return Report & Reliable Entry Point Alerts - Улправда
Will Sight Sciences Inc. stock outperform Dow Jones index2025 Top Decliners & AI Based Buy/Sell Signal Reports - Улправда
Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Tops Revenue Estimates - sharewise.com
Sight Sciences Earnings Notes - Trefis
Sight Sciences (SGHT) director and 10% owner buys 13,958 shares - Stock Titan
Exit Recap: Is Sight Sciences Inc. stock recession proofPortfolio Profit Report & Daily Chart Pattern Signals - Улправда
What Makes Sight Sciences, Inc. (SGHT) a Strong Momentum Stock: Buy Now? - Yahoo Finance
Sight Sciences, Inc. (NASDAQ:SGHT) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Sight Sciences price target raised to $9.10 from $5.50 at Citi - MSN
Lake Street Remains a Buy on Sight Sciences (SGHT) - The Globe and Mail
Lake Street Maintains Sight Sciences (SGHT) Buy Recommendation - Nasdaq
B Group Inc. Has $3.84 Million Position in Sight Sciences, Inc. $SGHT - Defense World
How currency fluctuations impact Sight Sciences Inc. stockMarket Sentiment Summary & Fast Momentum Stock Entry Tips - Newser
Sight sciences CFO Rodberg sells $20,773 in shares By Investing.com - Investing.com Australia
Sight sciences CFO Rodberg sells $20,773 in shares - Investing.com
Morgan Stanley Maintains Sight Sciences (SGHT) Equal-Weight Recommendation - MSN
Sight Sciences (SGHT) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
What Catalysts Are Changing the Story for Sight Sciences Investors? - Yahoo Finance
Sight Sciences’ chief legal officer Hayden sells $362k in shares By Investing.com - Investing.com South Africa
Sight Sciences (NASDAQ:SGHT) Insider Jeremy Hayden Sells 44,850 Shares - MarketBeat
Sight Sciences’ chief legal officer Hayden sells $362k in shares - Investing.com Australia
Sight Sciences Executive Sells Shares Under Trading Plan - TradingView — Track All Markets
Shareholder Link Files To Sell 12,544 Of Sight Sciences Inc [SGHT] - TradingView
Retail Investors Who Hold 30% of Sight Sciences, Inc. (NASDAQ:SGHT) Gained 13%, Institutions Profited as Well - 富途牛牛
Can PCS Technology Limited Sustain EPS Growth Under Competitive PressurePortfolio Allocation Tips & Fast Profit Strategies - earlytimes.in
Shareholder Link Files To Sell 30,000 Of Sight Sciences Inc [SGHT] - TradingView
Will Sight Sciences Inc. stock continue upward momentum2025 Buyback Activity & AI Enhanced Trading Alerts - newser.com
Sight Sciences, Inc. (NASDAQ:SGHT) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Sight Sciences Inc Stock (SGHT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
0.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):